These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 29314520)

  • 1. Localisation of occult extra-pancreatic insulinoma using glucagon-like peptide-1 receptor molecular imaging.
    Mossman AK; Pattison DA; Hicks RJ; Hamblin PS; Yates CJ
    Intern Med J; 2018 Jan; 48(1):97-98. PubMed ID: 29314520
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of Ga(68) -DOTA-exendin-4 PET/CT to localize an occult insulinoma.
    Cuthbertson DJ; Banks M; Khoo B; Antwi K; Christ E; Campbell F; Raraty M; Wild D
    Clin Endocrinol (Oxf); 2016 May; 84(5):789-91. PubMed ID: 26562613
    [No Abstract]   [Full Text] [Related]  

  • 3. Morphologically 'invisible' proinsulin - secreting adenoma detected by Ga-68 Exendin-4 (GLP-1 Receptor) positron emission tomography/CT.
    Werner C; Lupp A; Drescher R; Freesmeyer M; Mireskandari M; Stoykow C; Bauschke A; Müller UA
    J Med Imaging Radiat Oncol; 2018 Jun; 62(3):370-374. PubMed ID: 29399966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study.
    Antwi K; Fani M; Heye T; Nicolas G; Rottenburger C; Kaul F; Merkle E; Zech CJ; Boll D; Vogt DR; Gloor B; Christ E; Wild D
    Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2318-2327. PubMed ID: 30054698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study.
    Christ E; Wild D; Ederer S; Béhé M; Nicolas G; Caplin ME; Brändle M; Clerici T; Fischli S; Stettler C; Ell PJ; Seufert J; Gloor B; Perren A; Reubi JC; Forrer F
    Lancet Diabetes Endocrinol; 2013 Oct; 1(2):115-22. PubMed ID: 24622317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. For insulinomas, no place to hide.
    Nauck MA; Meier JJ
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4125-6. PubMed ID: 19890029
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of
    Kimura H; Matsuda H; Ogawa Y; Fujimoto H; Toyoda K; Fujita N; Arimitsu K; Hamamatsu K; Yagi Y; Ono M; Inagaki N; Saji H
    Bioorg Med Chem; 2017 Feb; 25(4):1406-1412. PubMed ID: 28089587
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Tuzcu SA; Pekkolay Z; Kılınç F; Tuzcu AK
    J Nucl Med Technol; 2017 Sep; 45(3):198-200. PubMed ID: 28798227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioiodinated Exendin-4 Is Superior to the Radiometal-Labelled Glucagon-Like Peptide-1 Receptor Probes Overcoming Their High Kidney Uptake.
    Läppchen T; Tönnesmann R; Eersels J; Meyer PT; Maecke HR; Rylova SN
    PLoS One; 2017; 12(1):e0170435. PubMed ID: 28103285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-radiolabeled GLP-1 analog exendin-4 for PET/CT imaging of insulinoma in small animals.
    Wu H; Liang S; Liu S; Pan Y; Cheng D; Zhang Y
    Nucl Med Commun; 2013 Jul; 34(7):701-8. PubMed ID: 23652208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 68Ga DOTA-Exendin PET/CT for Detection of Insulinoma in a Patient With Persistent Hyperinsulinemic Hypoglycemia.
    Parihar AS; Vadi SK; Kumar R; Mittal BR; Singh H; Bal A; Walia R; Shukla J; Sinha SK
    Clin Nucl Med; 2018 Aug; 43(8):e285-e286. PubMed ID: 29877881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging of Insulinoma by Targeting Glucagonlike Peptide-1 Receptor.
    Luo Y; Chen X
    PET Clin; 2021 Apr; 16(2):205-217. PubMed ID: 33589387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide-1 receptor imaging for localization of insulinomas.
    Christ E; Wild D; Forrer F; Brändle M; Sahli R; Clerici T; Gloor B; Martius F; Maecke H; Reubi JC
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4398-405. PubMed ID: 19820010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon-like peptide 1-receptor scans to localize occult insulinomas.
    Wild D; Mäcke H; Christ E; Gloor B; Reubi JC
    N Engl J Med; 2008 Aug; 359(7):766-8. PubMed ID: 18703486
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular imaging in the investigation of hypoglycaemic syndromes and their management.
    Pattison DA; Hicks RJ
    Endocr Relat Cancer; 2017 Jun; 24(6):R203-R221. PubMed ID: 28400403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiolabeled glucagon-like peptide-1 analogues: a new pancreatic β-cell imaging agent.
    Zhang Y; Chen W
    Nucl Med Commun; 2012 Mar; 33(3):223-7. PubMed ID: 22262216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma.
    Wicki A; Wild D; Storch D; Seemayer C; Gotthardt M; Behe M; Kneifel S; Mihatsch MJ; Reubi JC; Mäcke HR; Christofori G
    Clin Cancer Res; 2007 Jun; 13(12):3696-705. PubMed ID: 17575235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Improved detection of insulinoma using perfusion-CT].
    Baumgartner K; Bitzer M; Overkamp D; Lauer U; Horger M
    Rofo; 2020 Aug; 192(8):721-724. PubMed ID: 31853907
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pancreatic neuroendocrine neoplasms].
    Beiderwellen K; Sabet A; Lauenstein TC; Lahner H; Poeppel TD
    Radiologe; 2016 Apr; 56(4):348-54. PubMed ID: 27003413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 68Ga-NOTA-exendin-4 PET/CT in detection of occult insulinoma and evaluation of physiological uptake.
    Luo Y; Yu M; Pan Q; Wu W; Zhang T; Kiesewetter DO; Zhu Z; Li F; Chen X; Zhao Y
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):531-2. PubMed ID: 25398421
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.